Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.
作者信息
Kindel Tammy L, Wang Andrew Y, Wadhwa Anupama, Schulman Allison R, Sharaiha Reem Z, Kroh Matthew, Ghanem Omar M, Levy Shauna, Joshi Girish P, LaMasters Teresa
机构信息
Department of Surgery, Medical College of Wisconsin, 8700 Watertown Plank Road, Milwaukee, WI, 53226, USA.
Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA.
出版信息
Surg Endosc. 2025 Jan;39(1):180-183. doi: 10.1007/s00464-024-11263-2. Epub 2024 Oct 29.
Abstract
摘要
相似文献
1
Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.
Surg Endosc. 2025 Jan;39(1):180-183. doi: 10.1007/s00464-024-11263-2. Epub 2024 Oct 29.
2
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations.
Can J Anaesth. 2024 Sep;71(9):1302-1315. doi: 10.1007/s12630-024-02810-5. Epub 2024 Aug 26.
3
Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice.
Anaesthesia. 2024 Jul;79(7):735-747. doi: 10.1111/anae.16306. Epub 2024 May 13.
4
Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.
Surg Obes Relat Dis. 2024 Dec;20(12):1183-1186. doi: 10.1016/j.soard.2024.08.033. Epub 2024 Oct 29.
5
Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period.
Clin Gastroenterol Hepatol. 2024 Oct 29. doi: 10.1016/j.cgh.2024.10.003.
6
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association.
Anaesthesia. 2025 Apr;80(4):412-424. doi: 10.1111/anae.16541. Epub 2025 Jan 9.
7
Letter to the editor regarding multisociety clinical practice guidance - safe use of glucagon-like peptide-1 receptor agonists in perioperative period.
Surg Obes Relat Dis. 2025 Jun;21(6):695-696. doi: 10.1016/j.soard.2024.12.014. Epub 2024 Dec 21.
8
Response to Milder et al. "Letter to the editor regarding multisociety clinical practice guidance- safe use of glucagon-like peptide-1 receptor agonists in perioperative period".
Surg Obes Relat Dis. 2025 Jun;21(6):696. doi: 10.1016/j.soard.2025.01.012. Epub 2025 Feb 14.
9
Considerations for Perioperative Management Guidance Regarding GLP-1 Receptor Agonists: Evaluation of Current Practices and Future Directions.
Mil Med. 2025 Apr 23;190(5-6):e1022-e1028. doi: 10.1093/milmed/usaf029.
10
Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction.
Int J Clin Pharm. 2013 Apr;35(2):159-72. doi: 10.1007/s11096-012-9729-9. Epub 2012 Dec 22.
引用本文的文献
1
GLP-1 Receptor Agonist Use in Patients Undergoing Distal Radius Fracture Surgery: A Retrospective Review of Perioperative Considerations.
Cureus. 2025 Jul 31;17(7):e89183. doi: 10.7759/cureus.89183. eCollection 2025 Jul.
2
GLP-1 Receptor Agonists and Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus.
J Clin Med. 2025 Aug 7;14(15):5597. doi: 10.3390/jcm14155597.
3
The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions.
EClinicalMedicine. 2025 Jul 17;86:103363. doi: 10.1016/j.eclinm.2025.103363. eCollection 2025 Aug.
4
"Ozempic Face" in Plastic Surgery: A Systematic Review of the Literature on GLP-1 Receptor Agonist Mediated Weight Loss and Analysis of Public Perceptions.
Aesthet Surg J Open Forum. 2025 Jun 11;7:ojaf056. doi: 10.1093/asjof/ojaf056. eCollection 2025.
5
The fasting and the furious: reconciling fasting guidelines with glucagon-like peptide-1 receptor agonists, 'Sip-til-Send' policies and gastric ultrasound.
Anaesth Rep. 2025 Jun 10;13(1):e70015. doi: 10.1002/anr3.70015. eCollection 2025 Jan-Jun.
6
Tirzepatide for Obstructive Sleep Apnea: A Novel Therapeutic Promise and the Perioperative Considerations.
Indian J Otolaryngol Head Neck Surg. 2025 Jun;77(6):2430-2432. doi: 10.1007/s12070-025-05485-6. Epub 2025 Apr 28.
7
Fasting Before Cardiac Catheterization: Still Necessary? A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
J Am Heart Assoc. 2025 Jun 3;14(11):e040445. doi: 10.1161/JAHA.124.040445. Epub 2025 May 22.
8
Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis.
Anaesthesia. 2025 Jul;80(7):846-858. doi: 10.1111/anae.16601. Epub 2025 Apr 15.
本文引用的文献
1
Glucagon-Like Peptide 1 Receptor Agonist Use Before Surgery-Reply.
JAMA Surg. 2024 Sep 1;159(9):1093-1094. doi: 10.1001/jamasurg.2024.2307.
2
Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis With Insights for Periprocedural Management.
Am J Gastroenterol. 2024 Jun 1;119(6):1126-1140. doi: 10.14309/ajg.0000000000002820. Epub 2024 Apr 18.
3
Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia.
JAMA Surg. 2024 Jun 1;159(6):660-667. doi: 10.1001/jamasurg.2024.0111.
4
AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication.
Clin Gastroenterol Hepatol. 2024 Apr;22(4):705-707. doi: 10.1016/j.cgh.2023.11.002. Epub 2023 Nov 7.
5
Prevalence and variations in gastric emptying delay in response to GLP-1 receptor agonist liraglutide.
Obesity (Silver Spring). 2024 Feb;32(2):232-233. doi: 10.1002/oby.23941. Epub 2023 Nov 5.
6
Anesthetic Considerations in Adult Patients on Glucagon-Like Peptide-1 Receptor Agonists: Gastrointestinal Focus.
Anesth Analg. 2024 Jan 1;138(1):216-220. doi: 10.1213/ANE.0000000000006810. Epub 2023 Dec 15.
7
Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide.
Can J Anaesth. 2023 Aug;70(8):1300-1306. doi: 10.1007/s12630-023-02549-5. Epub 2023 Jul 19.
8
Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report.
Can J Anaesth. 2023 Aug;70(8):1397-1400. doi: 10.1007/s12630-023-02521-3. Epub 2023 Jun 6.
9
Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report.
Can J Anaesth. 2023 Aug;70(8):1394-1396. doi: 10.1007/s12630-023-02440-3. Epub 2023 Mar 28.
10
Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy.
J Clin Anesth. 2023 Aug;87:111091. doi: 10.1016/j.jclinane.2023.111091. Epub 2023 Mar 2.
Zotero 插件